/Investor DB

Waldencast — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

C16 Biosciencesc16bio.comin𝕏Series A · Apr 2020 · $20M

C16 Biosciences uses a biomanufacturing platform to produce sustainable alternatives to oils and fats for consumer product supply chains, with its first product being an alternative to palm oil.

BiotechCleantechClimate TechConsumerHealthtechNew MaterialsNew York City, US

Shara Ticku(Co-Founder & Chief Executive Officer)inDavid Heller(Co-Founder & Chief Operating Officer)inHarry McNamara(Founder)in

BoardAndrew Shumaker(He resigned as a Director effective November 20, 2018.)

Co-investorsBreakthrough Energy VenturesDCVC (Data Collective)Dorm RoomE12 Venture Capital, LlcEvolution VC PartnersG Ventures+20 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.